Occupational Lung Diseases Overview

Principles

Definition

Occupational lung diseases is a distinct field of study within occupational medicine and public health concerned with respiratory conditions caused or aggravated by workplace exposures. This research domain systematically investigates the etiology, pathogenesis, diagnosis, treatment, and prevention of lung diseases resulting from the inhalation of occupational agents such as dusts, fumes, gases, vapors, and biological agents, critically informing industrial hygiene, regulatory standards, and clinical practice.

Ontological type

Etiologic Agents

Prevention and Control

Pathophysiology

Key developments

Key Figures

Surveillance and Etiologic Discovery era

Irving J. Selikoff [1] was associated with Icahn School of Medicine at Mount Sinai [3] and the City University of New York [4] during this era. He contributed to identifying asbestos-related risks and smoking as a modifier through the 1968 paper Asbestos Exposure, Smoking, and Neoplasia [7], a finding that anchored surveillance-driven understandings of occupational carcinogenesis. Benjamin G. Ferris [2], with affiliations at Harvard University [5] and Boston University [6], produced several era-relevant epidemiologic studies. These papers [8], [9], and [10] advanced population-based surveillance and longitudinal follow-up methods that shaped early etiologic discovery and industrial hygiene practices.

Dose-Response Exposure Paradigm era

R Peslin [1] held appointments at McGill University [3] and Universitat de Barcelona [4] during this era. His key contributions in this dose–response era centered on standardizing lung function testing, as reflected in Lung volumes and forced ventilatory flows [5], which provided a framework for comparability across longitudinal spirometric data and dose–response analyses. Eva Hnizdo [2] advanced the dose–response framework through a systematic overview of occupational dust exposure and COPD, as exemplified by Occupation Dust Exposure and Chronic Obstructive Pulmonary Disease: A Systematic Overview of the Evidence [6]. This work underscored the value of synthesizing evidence to define dose-dependent exposure–response relationships and to inform exposure limits and surveillance strategies in industrial hygiene.

Integrated Surveillance and Phenotyping era

Jean Bourbeau [1] is a leading figure in occupational lung diseases during the Integrated Surveillance and Phenotyping era, with affiliations at Harvard University [3] and the University of California, San Francisco [4]. This body of work reflects standardized COPD frameworks and national guideline development, exemplified by the Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report: GOLD Executive Summary [7] and the Canadian Thoracic Society Recommendations for Management of Chronic Obstructive Pulmonary Disease – 2007 Update [8], which helped harmonize surveillance and phenotyping across populations. Peter J. Barnes [2] has been linked with University of Pennsylvania [5] and Park University [6] during this era. His key contribution centers on the GOLD 2017 Executive Summary [7], whose recommendations advanced standardized COPD diagnosis and management and informed risk-based surveillance and prevention strategies.